334 related articles for article (PubMed ID: 33195402)
1. Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches.
Waqas M; Haider A; Sufyan M; Siraj S; Sehgal SA
Front Mol Biosci; 2020; 7():227. PubMed ID: 33195402
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.
Waqas M; Haider A; Rehman A; Qasim M; Umar A; Sufyan M; Akram HN; Mir A; Razzaq R; Rasool D; Tahir RA; Sehgal SA
Biomed Res Int; 2021; 2021():1596834. PubMed ID: 33728324
[TBL] [Abstract][Full Text] [Related]
3. Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
Sajid M; Marriam S; Mukhtar H; Sohail S; Sajid M; Sehgal SA
PLoS One; 2022; 17(3):e0264700. PubMed ID: 35324925
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.
Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R
Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206
[TBL] [Abstract][Full Text] [Related]
5. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets.
Mukherjee S; Tworowski D; Detroja R; Mukherjee SB; Frenkel-Morgenstern M
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32526960
[TBL] [Abstract][Full Text] [Related]
7. Integrative immunoinformatics paradigm for predicting potential B-cell and T-cell epitopes as viable candidates for subunit vaccine design against COVID-19 virulence.
Sarma VR; Olotu FA; Soliman MES
Biomed J; 2021 Aug; 44(4):447-460. PubMed ID: 34489196
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2.
Kumar V; Kancharla S; Kolli P; Jena M
F1000Res; 2021; 10():44. PubMed ID: 33841800
[No Abstract] [Full Text] [Related]
9. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
Anand R; Biswal S; Bhatt R; Tiwary BN
PeerJ; 2020; 8():e9855. PubMed ID: 33062414
[TBL] [Abstract][Full Text] [Related]
10. Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.
Sarkar B; Ullah MA; Araf Y; Rahman MS
Inform Med Unlocked; 2020; 21():100478. PubMed ID: 33200088
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
12. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.
Ashik AI; Hasan M; Tasnim AT; Chowdhury MB; Hossain T; Ahmed S
Heliyon; 2020 Sep; 6(9):e04865. PubMed ID: 32923731
[TBL] [Abstract][Full Text] [Related]
13. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
[TBL] [Abstract][Full Text] [Related]
14. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
[TBL] [Abstract][Full Text] [Related]
15. An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2.
Jakhar R; Gakhar SK
Can J Infect Dis Med Microbiol; 2020; 2020():7079356. PubMed ID: 33299503
[TBL] [Abstract][Full Text] [Related]
16. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
17. Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic.
Di Natale C; La Manna S; De Benedictis I; Brandi P; Marasco D
Front Pharmacol; 2020; 11():578382. PubMed ID: 33343349
[TBL] [Abstract][Full Text] [Related]
18. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].
Zhao J; Mao Y; Dong R; Tong X; Zhang Q; Zha Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jun; 37(6):487-494. PubMed ID: 34060442
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach.
Ghorbani A; Zare F; Sazegari S; Afsharifar A; Eskandari MH; Pormohammad A
New Microbes New Infect; 2020 Nov; 38():100786. PubMed ID: 33072338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
